Moving Stocks: Magellan Petroleum Corporation (NASDAQ:MPET), Potbelly Corporation (NASDAQ:PBPB), GlaxoSmithKline plc (NYSE:GSK), Opexa Therapeutics, Inc. (NASDAQ:OPXA), The Gap, Inc. (NYSE:GPS)

On July 27, 2015, Magellan Petroleum Corporation (Nasdaq:MPET) received formal notification from the NASDAQ Stock Market LLC (“NASDAQ”) that the Company has regained compliance with Listing Rule 5550(a)(2), which requires the Company to maintain a minimum closing bid price of $1.00 per share. NASDAQ staff made this determination of compliance after the Company’s bid price closed above $1.00 per share for the prior 10 consecutive business days. Magellan Petroleum Corporation (NASDAQ:MPET) belongs to Basic Materials sector. Its weekly performance is -11.81%. On last trading day company shares ended up $2.09. Magellan Petroleum Corporation (NASDAQ:MPET) distance from 50-day simple moving average (SMA50) is -31.04%.

Potbelly Corporation (NASDAQ:PBPB) today reported financial results for the second fiscal quarter ended June 28, 2015. Aylwin Lewis, Chairman and Chief Executive Officer of Potbelly Corporation, commented, “We’ve achieved three consecutive quarters of solid sales growth and strong profitability. Our total revenue increased 14.7% to $95.9 million, our adjusted EBITDA increased 17.5% to $11.8 million and adjusted net income increased 45.6% to $3.0 million, or $0.10 per diluted share.” He continued, “The Potbelly teams continue doing great work and we are pleased with the first half of the year. We remain confident in the fundamentals of our business and our ability to achieve our previously disclosed guidance for the full year. Potbelly Corporation (NASDAQ:PBPB) shares moved down -11.67% in last trading session and ended the day at $12.26. PBPB Gross Margin is 71.40% and its return on assets is 2.70%. Potbelly Corporation (NASDAQ:PBPB) quarterly performance is -14.56%.

GlaxoSmithKline Pharmaceuticals (GSK India) has said its greenfield manufacturing facility at Bengaluru, having an installed capacity of over 9 billion tablets and capsules per year, will be operational by 2017. “The company has decided to create a new greenfield manufacturing site at Vemgal near Bengaluru, to be operational by 2017. Initially, the site will supply a range of solid dose form products. The unit will have an installed annual capacity of over 9 billion tablets and capsules to supply in the local market,” the company said in its annual report. On 05 August, GlaxoSmithKline plc (NYSE:GSK) shares moved up 1.66% and was closed at $44.17. GSK EPS growth in last 5 year was -12.10%. GlaxoSmithKline plc (NYSE:GSK) year to date (YTD) performance is 6.23%.

Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing personalized immunotherapies for autoimmune disorders, including multiple sclerosis (MS) and neuromyelitis optica (NMO), today announced that the Company will report financial results for the three months ended June 30, 2015 after the close of trading on Wednesday, August 12th. The Company will also conduct a conference call and webcast to discuss financial results and provide a corporate update at 5:00 P.M. EDT on Wednesday, August 12th. Opexa Therapeutics, Inc. (NASDAQ:OPXA) ended the last trading day at $0.39. Company weekly volatility is calculated as 6.74% and price to cash ratio as 2.17. Opexa Therapeutics, Inc. (NASDAQ:OPXA) showed a weekly performance of -3.95%.

On Jul 23, 2015 GT Nexus announced that The Gap, Inc. (NYSE:GPS) has been named the winner of the 2015 Innovation Award. The award was given at Bridges 2015, the leading cloud supply chain industry event held June 8-11 in Hollywood, Florida. The Gap, Inc. (NYSE:GPS) shares moved up 0.09% in last trading session and ended the day at $35.19. GPS Gross Margin is 38.00% and its return on assets is 16.20%. The Gap, Inc. (NYSE:GPS) quarterly performance is -10.78%.

Leave a Reply

Your email address will not be published. Required fields are marked *